Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Study for Rasagiline Effect on Sleep Trial in Parkinson's Disease
- Study Title
- Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease
- Teva Identifier
- TNC-RAS-PD/01 | REST
- ClinicalTrials.gov Identifier
- NCT01032486
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: Rasagiline mesylate
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age Range
- Child, Adult, Older Adult
- Trial Duration
- 12/01/2009 - 07/01/2011
